Groups | Glucose (mg∙dl−1) | Insulin (µU∙ml−1) | Insulin Resistance |
Control | 81.9 ± 4.3 | 5.5 ± 0.7 | 3.3 ± 0.07 |
HCD Control | 160.9 ± 12.2a*** | 14.8 ± 1.5a* | 5.3 ± 1.6a* |
HCD + Orlistat | 128.5 ± 13.1b*** | 18.0 ± 1.2b* | 3.1 ± 0.8b* |
HCD + EEB (100 mg∙kg−1 BW) | 137.4 ± 10.6b** | 15.4 ± 1.9b* | 4.4 ± 1.2b* |
HCD + EEB (200 mg∙kg−1 BW) | 132.1 ± 2.6b** | 15.8 ± 0.8b* | 3.8 ± 1.2b* |
HCD + EEB (300 mg∙kg−1 BW) | 129.7 ± 15.3b** | 16.6 ± 0.7b* | 3.2 ± 0.6b* |